Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.
WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth
★★★★★ TopFund est.
TopFund Score (fallback rating)
- Calculated by: TopFund — used only when no third-party rating exists for this fund
- Formula: 3-year trailing return percentile within category, adjusted ±1 star for expense ratio
- Refresh frequency: Whenever TopFund re-syncs this fund's data
- Limitations: A simplified 2-factor estimate, not equivalent to a rating agency's full analysis
TopFund Score: 72/100 · Good
How this score is calculated
- Star rating (35%)4/5
- 3Y CAGR (30%)—
- Expense ratio (20%)1.06%
- AUM (15%)₹1,003 Cr
Not investment advice — an analytical read of public fund data. Methodology →
WhiteOak Capital Mutual Fund · Equity · Sectoral
₹17.8
AUM: ₹1,002 Cr
NAV updated 14 days ago
Plan
Regular
Option
Growth
Risk
Very High
Expense Ratio
1.06%
Exit Load
Nil
Fund Manager
Ashish Agrawal
Inception
Feb 2024
Benchmark
BSE Healthcare Total Return Index
Sharpe Ratio
1.09
Std Dev (1Y)
14.05%
Historical Returns (CAGR)
Annualized trailing returns computed from NAV history — past performance only, not a guarantee of future results.
1m
+4.29%
3m
+2.5%
6m
+17.96%
1y
+20.62%
3y
—
5y
—
10y
—
since inception
+20.95%
TopFund's Take on WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth
WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth holds up reasonably well within the Sectoral category, backed by a 4-star rating. Recent 1-year performance has been notably strong, though momentum like this doesn't always hold over longer periods. TopFund's composite Health Score, which weighs rating, 3-year CAGR, expense ratio and fund size, puts it at 72/100.
Cost: At 1.06%, the expense ratio is roughly in line with the Sectoral category average of 1.0% — cost isn't a standout factor either way for this fund.
Risk-adjusted performance: Over the trailing 1-year period, the fund shows a strong Sharpe ratio of 1.09 — the fund has generated solid returns relative to the volatility it exposed investors to. Separately, annualised volatility of 14.05% is fairly typical for Sectoral funds.
Who should invest: This fund is best suited to investors whose goals and risk appetite align with a Equity fund. Given the Very High risk rating, this fund is not suited to short-term goals or investors who may need to exit within 2-3 years.
This is an automated, data-driven analysis based on the fund's own metrics and its category peers — not personalized investment advice. Consult a SEBI-registered advisor before investing.
Sector Allocation
Asset Allocation
Fund Snapshot
Similar Funds
SBI Arbitrage Opportunities Fund - Direct Plan - Gr
SBI Mutual Fund
Franklin India Technology Fund-Growth
Franklin Templeton Mutual Fund
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH
SBI Mutual Fund
DSP Nifty Healthcare Index Fund - Direct- Growth
DSP Mutual Fund
Franklin India Technology Fund - Direct - Growth
Franklin Templeton Mutual Fund
BANK OF INDIA Manufacturing & Infrastructure Fund-Growth
Bank of India Mutual Fund
Tools & Guides for This Fund
Frequently Asked Questions about WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth
The current NAV (Net Asset Value) of WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth is ₹17.8. NAV is updated every business day after market close by AMFI.
1Y: 20.62%
The expense ratio of WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth is 1.06% per annum. This is the annual fee charged by the fund to manage your investment.
WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth is managed by Ashish Agrawal at WhiteOak Capital Mutual Fund.
WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth is classified as a Very High risk fund. It is suitable for aggressive investors with a long-term horizon of 5+ years.
WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth is a Sectoral fund. SIP suitability depends on your investment goal and risk profile.
You can start a SIP in WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth with as little as ₹500 per month through most mutual fund platforms. The minimum lump sum investment is typically ₹1,000.
The Assets Under Management (AUM) of WhiteOak Capital Pharma and Heathcare Fund Regular Plan Growth is ₹1,003 crore. AUM indicates the total market value of assets managed by the fund.
* Past performance is not indicative of future results. Mutual fund investments are subject to market risks.
Discussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
No comments yet — start the discussion.